KLK10 and prostate cancer: Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK10 is one of the fifteen kallikrein subfamily members which encodes a secreted protein and may play a role in suppression of tumorigenesis in breast and prostate cancers.